Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
{{familytree | | | | |E01| | | | | E02 | | | | E03 | | |E01=Additional tests specific to location of metastasis|E02=• Octreoscan<br> • Plasma chromogranin A|E03=Gender specific tests}} | {{familytree | | | | |E01| | | | | E02 | | | | E03 | | |E01=Additional tests specific to location of metastasis|E02=• Octreoscan<br> • Plasma chromogranin A|E03=Gender specific tests}} | ||
{{familytree | | | | | |!| | | | | | | | | | | | |!| | }} | {{familytree | | | | | |!| | | | | | | | | | | | |!| | }} | ||
{{familytree | |,|-|-|-|+|-|-|-|. | {{familytree | |,|-|-|-|+|-|-|-|.| | | | | | |,|-|^|-|.| | | | }} | ||
{{familytree | F01 | |F02| | F03 | | | | | F04 | | F05| | | |F01= | {{familytree | F01 | |F02| | F03 | | | | | F04 | | F05| | | |F01=Cervical adenopathy|F02=Inguinal adenopathy|F03=Bone metastasis|F04='''male'''|F05='''Female'''}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:51, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Neuroendocrine carcinoma | Adenocarcinoma and poorly differntiated carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||
| Additional tests specific to location of metastasis | • Octreoscan • Plasma chromogranin A | Gender specific tests | |||||||||||||||||||||||||||||||||||||||||||||||
| Cervical adenopathy | Inguinal adenopathy | Bone metastasis | male | Female | |||||||||||||||||||||||||||||||||||||||||||||